title: Efficacy of bortezomib in combination chemotherapy on secondary plasma cell leukemia.
authors.forename: Ridvan
authors.initials: R
authors.lastname: Ali
authors.forename: Meral
authors.initials: M
authors.lastname: Beksac
authors.forename: Fahir
authors.initials: F
authors.lastname: Ozkalemkas
authors.forename: Vildan
authors.initials: V
authors.lastname: Ozkocaman
authors.forename: Atilla
authors.initials: A
authors.lastname: Ozkan
authors.forename: Tulay
authors.initials: T
authors.lastname: Ozcelik
authors.forename: Ahmet
authors.initials: A
authors.lastname: Tunali
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D006801:Humans; D007952:Leukemia, Plasma Cell / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000473:pathology; D016609:Neoplasms, Second Primary / Q000175:diagnosis / Q000188:drug therapy*; D011719:Pyrazines / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib